LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent

LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent

Bibliographic Details
Main Author:	Dagmar Zweytick
Format:	Article
Language:	English
Published:	Shared Science Publishers OG 2019-11-01
Series:	Cell Stress
Subjects:	antitumor peptide immunotherapeutic agent melanoma sarcoma
Online Access:	http://www.cell-stress.com/researcharticles/2019a-zweytick-cell-stress/

Similar Items

LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects
by: Hsin-Wei Liao, et al.
Published: (2019-10-01)

Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model
by: Janne Nestvold, et al.
Published: (2017-08-01)

Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response
by: Derry K. Mercer, et al.
Published: (2020-09-01)

Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma
by: Theresa Maxian, et al.
Published: (2021-08-01)

Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators
by: Tilahun Ayane Debele, et al.
Published: (2020-12-01)

Antitumor Peptides from Marine Organisms
by: Mi Sun, et al.
Published: (2011-10-01)

LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells
by: Takahiro Yamazaki, et al.
Published: (2021-01-01)

Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers
by: Zhen Dong, et al.
Published: (2021-01-01)

Cell cycle progression data on human skin cancer cells with anticancer synthetic peptide LTX-315 treatment
by: Gloria A. Santa-González, et al.
Published: (2020-06-01)

Extracting (1,3/1,6)-β-Glucans from Saccharomyces cerevisiae: A Fungal Immunotherapeutic
by: Elliott, James C
Published: (2016)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
by: Jiacheng Huang, et al.
Published: (2021-08-01)

Immunotherapeutic Potential of m6A-Modifiers and MicroRNAs in Controlling Acute Myeloid Leukaemia
by: Sunil Kumar, et al.
Published: (2021-06-01)

Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model
by: Ketil A. Camilio, et al.
Published: (2019-01-01)

Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures
by: Xinke Zhang, et al.
Published: (2021-08-01)

In vitro antitumor and hypotensive activity of peptides from olive seeds
by: Romy Vásquez-Villanueva, et al.
Published: (2018-03-01)

Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral Agent
by: Felix Sellberg, et al.
Published: (2021-01-01)

Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV
by: Lili Wang, et al.
Published: (2019-11-01)

Schiff Bases: Interesting Scaffolds with Promising Antitumoral Properties
by: Domenico Iacopetta, et al.
Published: (2021-02-01)

Novel Peptide CM 7 Targeted c-Met with Antitumor Activity
by: Chunlei Xia, et al.
Published: (2020-01-01)

Biological studies on heat-killed mycobacterium vaccae
by: Ustianowski, Andrew Peter
Published: (2002)

Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides
by: Kelly eMulder, et al.
Published: (2013-10-01)

An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
by: Xinmin Wang, et al.
Published: (2021-03-01)

Immunomodulatory and antitumor properties of polysaccharide peptide (PSP)
by: Jakub Piotrowski, et al.
Published: (2015-01-01)

WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma
by: Qihang Yuan, et al.
Published: (2021-06-01)

CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets
by: Liu F, et al.
Published: (2021-02-01)

Marine Antitumor Peptide Dolastatin 10: Biological Activity, Structural Modification and Synthetic Chemistry
by: Gang Gao, et al.
Published: (2021-06-01)

Progress of Entirely Carbohydrate Conjugates in Cancer Immunotherapeutics – Syntheses and Developments
by: Kleski, Kristopher A.
Published: (2020)

Rhenium(I) Complexes with Pincer Ligands as a New Class of Potential Antitumor Agents
by: Diana V. Aleksanyan, et al.
Published: (2019-08-01)

The Antimicrobial Peptide Melectin Shows Both Antimicrobial and Antitumor Activity via Membrane Interference and DNA Binding
by: Liang X, et al.
Published: (2021-03-01)

Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae
by: Jutamas Shaughnessy, et al.
Published: (2020-10-01)

An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)
by: Wen Jiang, et al.
Published: (2020-04-01)

Immunotherapeutic Effects of β-D Mannuronic Acid on IL-4, GATA3, IL-17 and RORC Gene Expression in the PBMC of Patients with Inflammatory Bowel Diseases
by: Hussaini Alhassan Mohammed, et al.
Published: (2018-08-01)

Current and Novel Approaches in Influenza Management
by: Erasmus Kotey, et al.
Published: (2019-06-01)

Antitumor Effects of Self-Assembling Peptide-Emodin in situ Hydrogels in vitro and in vivo
by: Wei W, et al.
Published: (2021-01-01)

Antifungal and antitumor models of bioactive protective peptides
by: Elaine G. Rodrigues, et al.
Published: (2009-09-01)

Enhanced T-lymphocyte infiltration in a desmoid tumor of the thoracic wall in a young woman treated with intratumoral injections of the oncolytic peptide LTX-315: a case report
by: Nina Louise Jebsen, et al.
Published: (2019-06-01)

Visible and subvisible particles in the BCG immunotherapeutic product ImmuCyst®
by: Marina Kirkitadze, et al.
Published: (2016-01-01)

Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs
by: Pavel M. Kopeikin, et al.
Published: (2020-10-01)

Synthesis and Antitumor Activity of 5-Trifluoromethyl-2,4- dihydropyrazol-3-one Nucleosides
by: Hussein F.. Zohdi, et al.
Published: (2004-02-01)

<i>Cereus jamacaru</i> D.C. Hydroalcoholic Extract Promotes Anti-Cytotoxic and Antitumor Activity
by: Jean Carlos Vencioneck Dutra, et al.
Published: (2018-11-01)